论文部分内容阅读
据新华网报道,中华医学会肝病学分会主任委员、北京大学肝病研究所所长魏来日前发布中国丙肝病毒和人类基因多态性流行病学调查显示,大部分受访者对丙肝及其危害缺乏认知,有60%的丙肝患者感染了病毒却不自知,15%的患者确诊时已进入晚期。魏来介绍,在中国约有1000万人感染丙型肝炎病毒,若能及时发现,并给予及时、正确、合理的抗病毒治疗,丙肝是可以治愈的。聚乙二醇干扰素α联合利巴韦林是目前现有普遍使用的慢性丙肝抗病毒治疗方案。然而,调查显示,我国当前丙肝防
According to Xinhuanet reported that the Chinese Medical Association liver disease credits director, Peking University Institute of Liver Diseases Wei Lai recently released China’s hepatitis C virus and human genetic polymorphism epidemiological survey showed that most respondents on hepatitis C and its harm Lack of cognition, 60% of hepatitis C patients infected with the virus but do not know, 15% of patients have entered the advanced diagnosis. Wei Lai introduced in China about 10 million people infected with hepatitis C virus, if promptly discovered, and give timely, correct and reasonable antiviral treatment, hepatitis C can be cured. Peginterferon alfa and ribavirin are the commonly used chronic hepatitis C antiviral treatment programs. However, the survey shows that our current anti-HCV prevention